tirofiban has been researched along with Diabetes Mellitus, Adult-Onset in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbieri, L; De Luca, G; Marino, P; Schaffer, A; Verdoia, M | 1 |
Angiolillo, D; Arora, U; Atar, D; Malinin, A; Pokov, A; Serebruany, V | 1 |
2 other study(ies) available for tirofiban and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
[Two catheters for one coronary perforation].
Topics: Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Antihypertensive Agents; Aspirin; Cardiac Catheterization; Catheters; Combined Modality Therapy; Diabetes Mellitus, Type 2; Dyslipidemias; Femoral Artery; Heart Injuries; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Male; Percutaneous Coronary Intervention; Premedication; Radial Artery; Stents; Tirofiban; Tyrosine | 2015 |
Effects of escalating doses of tirofiban on platelet aggregation and major receptor expression in diabetic patients: hitting the TARGET in the TENACITY trial?
Topics: Aged; Blood Platelets; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Cell Surface; Tirofiban; Tyrosine | 2007 |